期刊文献+

有限采样法监测口服麦考酚钠肠溶片的肾移植受者血麦考酚酸浓度的研究 被引量:3

Limited sampling strategies predicting mycophenolic acid area-under-the-curve in Chinese renal transplant recipients receiving enteric-coated mycophenolate sodium and tacrolimus
原文传递
导出
摘要 目的研究肾移植受者口服麦考酚钠肠溶片(EC-MPS)后血麦考酚酸(MPA)药代动力学特征,并通过有限采样法研究0~12h的药物曲线下面积(AUC0-12h)。方法按照入选和排除标准筛选20例接受EC-MPS+他克莫司+泼尼松三联免疫抑制治疗的汉族肾移植受者作为研究对象,在肾功稳定期(肾移植术后21d)监测受者口服EC-MPS后10个时间点(服药药后0.5、1、1.5、2、3、4、6、8、10和12h)的血浆MPA水平,应用Jackknife技术、多元线性回归分析以及Origin专业函数绘图软件(7.5版)来分析计算MPAAUC。结果口服EC-MPS后,20例受者间血浆MPA水平及AUC变异很大。最佳有限采样法有三点法(血MPA浓度检测时间点为1.5、4和8h)和四点法(血MPA浓度检测时间点为1.5、4、6和8h),公式分别为AUCo-12h=12.820+0.662×C15h+1.750×C4h+4.213×C8h以及AUCo-12h=12.119+0.676×C115h+1.685×C4h+1.429XC6h+2.573×C8h。三点法校整的相关系数(R)=0.861,P〈0.001;四点法校正的相关系数R=0.882,P〈0.001。结论对于采用EC-MPS+他克莫司+泼尼松三联免疫抑制方案的汉族肾移植受者,在服药后1.5、4和8h或者1.5、4、6和8h进行有限采样法监测血浆MPA浓度,能够估算EC-MPS的AUC。 Objective To investigate the pharmacokinetic (PK) characteristics of enteric-coated mycophenolate sodium (EC-MPS) and area under the curve (AUC) from 0 to 12 h by limited sampling strategies (LSSs) in de novo kidney transplant patients of Chinese ethnicity. Method The PK data from 20 Chinese renal transplant recipients collected during the maintenance period after transplantation were analyzed retrospectively. Ten blood samples were obtained after EC-MPS was given on the postoperative day 21. Blood concentrations of mycophenolic acid were measured and AUC was estimated using high performance liquid chromatography in recipients receiving immunosuppressant EC-MPS plus tacrolimus and steroid. LSSs with jackknife technique, multiple stepwise regression analysis, and Origin 7. 5 analysis were developed to estimate mycophenolic acid (MPA) AUC. Result There was wide inter-individual variation in MPA plasma level and the AUC. The best equations obtained in the test group were for 3 and 4 time points: AUCo-12h (mg h L-1) = 12. 820 + 0. 662 × C1.5h q- 1. 750 × C4h q- 4. 213 ×Csh, and AUC0-12h (mg h L-1 ) = 12. 119 + 0. 676× C1.5h + 1. 685 × C4h + 1. 429 × C6h + 2. 573 × Csh respectively. When these LSSs were. tested in the validation group, the results were acceptable (R = 0. 861 ,P〈0. 001 for 3 time points, and R = 0. 882, P〈0. 001 for 4 time points). Conclusion LSSs are useful for MPA AUGya2h estimation in Chinese renal transplantation patients. LSSs using time points at C1. 5h-C4h-C4h - C8b C15h-C4h-C6h-C8 sh provide the most reliable and accurate estimation of the AUC0-12h of mycophenolic acid in Chinese stable renal transplant recipients receiving EC-MPS and tacrolimus.
出处 《中华器官移植杂志》 CAS CSCD 北大核心 2014年第8期473-478,共6页 Chinese Journal of Organ Transplantation
基金 山东省自然科学基金(ZR2013HL025)
关键词 有限采样法 肾移植 曲线下面积 麦考酚酸 Limited-sampling strategy Kidney transplantation Area under curve Mycophenolic acid
  • 相关文献

参考文献1

二级参考文献23

  • 1Pelletier RP, Akin B, Henry ML, Bumgardner GL, Elkhammas EA, Rajab A, et al. The impact of mycophenolate mofetil dosing patterns on outcomes in renal transplantation. Clin Transplant 2003; 17: 200-205.
  • 2Sfinchez Fructuoso A, Calvo N, Moreno MA, Conesa J, Barrientos A. Better mycophenolic acid 12-hour trough level after enteric-coated mycophenolate sodium in patients withgastrointestinal intolerance to mycophenolate mofetil. Transplant Proc 2007; 39: 2194-2196.
  • 3Langone A J, Chan L, Bolin P, Cooper M. Enteric-coated mycophenolate sodium versus mycophenolate mofetil in renal transplant recipients experiencing gastrointestinal intolerance: a multicenter, double-blind, randomized study. Transplantation 2011; 91: 470-478.
  • 4Reyes H, Hemgndez AM, Valverde S, Cataneo A, Mendoz A, Barrera I. Efficacy and safety of conversion o[ mycophenolate mofetil to enteric-coated mycophenolat1 sodium in Mexican renal transplant children. Pediatt Transplantation 2010; 14: 746-752. |.
  • 5Baraldo M, Cojutti PG, lsola M, Feruglio MT, Tursi V, Livi U, et al. Validation of limited sampling strategy for estimation of mycophenolic acid exposure during the first year after heart transplantation. Transplant Proc 2009; 41: 4277-4284.
  • 6Zhang Q, Tao YF, Zhu YB, Zhu D. Bioequivalence and pharmacokinetic comparison of two mycophenolate mofetil formulations in healthy Chinese male volunteers: An open-label, randomized-sequence, single-dose, two-way crossover study. Clin Ther 2010; 32: 171-178.
  • 7Jiao Z, Zhong JY, Zhang M, Shi XJ, Yu YQ, Lu WY. Total and free mycophenolic acid and its 7-O-glucuronide metabolite in Chinese adult renal transplant patients: Pharmacokinetics and application of limited sampling strategies. Eur J Clin Pharmacol 2007; 63: 27-37.
  • 8Yu ZC, Zhou P J, Xu D, Wang XH, Chen HZ. Investigation on pharmacokinetics of mycophenolic acid in Chinese adult renal transplant patients. Br J Clin Pharmacol 2006; 62: 446-452.
  • 9Sheiner LB, Beal SL. Some suggestions for measuring predictive performance. J Pharmacokinetic Biopharm 1981; 4: 503-512.
  • 10Gong NQ, Ming CS, Zeng F J, Zhang WJ, Lin ZB, Zhou P, et al. Renal function of donors and recipients after living donor kidney transplantation in a Chinese cohort. Chin Med J 201 l; 124: 1290-1295.

共引文献7

同被引文献17

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部